Literature DB >> 27655877

Irreversible electroporation in the curative treatment of Ewing's sarcoma.

Kacie Steinbrecher1, Bulent Arslan1, Michele L Nassin2, Paul Kent1.   

Abstract

Ewing's sarcoma (ES) is the second most common paediatric cancer of the bone. Standard therapy includes surgery or radiation for local control of primary and relapsed lesions and chemotherapy for systemic control. Irreversible electroporation (IRE), which uses short electrical pulses to induce pores and ablate neoplastic cells, has emerged as an alternative method of local control for inoperable metastatic liver and lung lesions. We present the first case in which IRE was used for local control of bony ES. This method has achieved successful local tumour control in our patient for 3 years. 2016 BMJ Publishing Group Ltd.

Entities:  

Year:  2016        PMID: 27655877      PMCID: PMC5051411          DOI: 10.1136/bcr-2016-216585

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Irreversible electroporation: implications for prostate ablation.

Authors:  Gary Onik; Paul Mikus; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

2.  Ablation of perivascular hepatic malignant tumors with irreversible electroporation.

Authors:  T Peter Kingham; Ami M Karkar; Michael I D'Angelica; Peter J Allen; Ronald P Dematteo; George I Getrajdman; Constantinos T Sofocleous; Stephen B Solomon; William R Jarnagin; Yuman Fong
Journal:  J Am Coll Surg       Date:  2012-06-16       Impact factor: 6.113

3.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

Authors:  Ruth Ladenstein; Ulrike Pötschger; Marie Cécile Le Deley; Jeremy Whelan; Michael Paulussen; Odile Oberlin; Henk van den Berg; Uta Dirksen; Lars Hjorth; Jean Michon; Ian Lewis; Alan Craft; Heribert Jürgens
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

4.  Theory of electroporation of planar bilayer membranes: predictions of the aqueous area, change in capacitance, and pore-pore separation.

Authors:  S A Freeman; M A Wang; J C Weaver
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

Review 5.  Epidemiology of childhood cancer.

Authors:  Peter Kaatsch
Journal:  Cancer Treat Rev       Date:  2010-03-15       Impact factor: 12.111

6.  High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation.

Authors:  S Burdach; A Meyer-Bahlburg; H J Laws; R Haase; B van Kaik; B Metzner; A Wawer; R Finke; U Göbel; J Haerting; H Pape; H Gadner; J Dunst; H Juergens
Journal:  J Clin Oncol       Date:  2003-08-15       Impact factor: 44.544

7.  The effect of irreversible electroporation on blood vessels.

Authors:  Elad Maor; Antoni Ivorra; Jonathan Leor; Boris Rubinsky
Journal:  Technol Cancer Res Treat       Date:  2007-08

Review 8.  Systematic review of ablation techniques for the treatment of malignant or aggressive benign lesions in children.

Authors:  Fernando M Gómez; Premal A Patel; Samuel Stuart; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2014-05-13

9.  The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients.

Authors:  W van den Bos; D M de Bruin; R R Jurhill; C D Savci-Heijink; B G Muller; I M Varkarakis; A Skolarikos; P J Zondervan; M P Laguna-Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  World J Urol       Date:  2015-08-22       Impact factor: 4.226

10.  Palliative treatment of presacral recurrence of endometrial cancer using irreversible electroporation: a case report.

Authors:  Christoph Niessen; Ernst-Michael Jung; Andreas G Schreyer; Walter A Wohlgemuth; Benedikt Trabold; Joachim Hahn; Michael Rechenmacher; Christian Stroszczynski; Philipp Wiggermann
Journal:  J Med Case Rep       Date:  2013-05-13
View more
  1 in total

1.  Case report: Irreversible electroporation for locally advanced pancreatic cancer.

Authors:  Sonia Orcutt; Bela Kis; Mokenge Malafa
Journal:  Int J Surg Case Rep       Date:  2017-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.